Xiaohan Lou
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Immunotherapy and Immune Responses
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- RNA Interference and Gene Delivery 3
- Extracellular vesicles in disease 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Immune cells in cancer 5
- Immunotherapy and Immune Responses 4
- Co-authors
- Zhihai Qin (20 shared papers)Xiaohan Yao (16 shared papers)Ni Chen (13 shared papers)Jiajia Wan (12 shared papers)Zhuoyu Gu (4 shared papers)Xiaomeng Liu (3 shared papers)Ming Wang (7 shared papers)Linyu Zhu (7 shared papers)
In The Last Decade
Xiaohan Lou
21 papers receiving 384 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 69
- Immunology 80
- Oncology 75
- Molecular Biology 186
- Biomaterials 32
Countries citing papers authored by Xiaohan Lou
This map shows the geographic impact of Xiaohan Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Lou more than expected).
Fields of papers citing papers by Xiaohan Lou
This network shows the impact of papers produced by Xiaohan Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Lou. The network helps show where Xiaohan Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaohan Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 70 | |
| 2 | 2023 | 53 | |
| 3 | 2018 | 44 | |
| 4 | 2020 | 32 | |
| 5 | 2022 | 31 | |
| 6 | 2019 | 27 | |
| 7 | 2022 | 22 | |
| 8 | 2024 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 10 | |
| 13 | 2025 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2022 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2024 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 1 |
About Xiaohan Lou
Xiaohan Lou is a scholar working on Molecular Biology, Immunology, Cancer Research, Oncology and Molecular Medicine, having authored 21 papers that have together received 386 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Immune cells in cancer (5 papers), Immunotherapy and Immune Responses (4 papers), Angiogenesis and VEGF in Cancer (3 papers), RNA Interference and Gene Delivery (3 papers), Curcumin's Biomedical Applications (2 papers), Extracellular vesicles in disease (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (69 citations), Immunology (80 citations), Oncology (75 citations), Molecular Biology (186 citations) and Biomaterials (32 citations). Xiaohan Lou has collaborated with scholars based in China, Germany and Singapore. Frequent co-authors include Zhihai Qin, Xiaohan Yao, Ni Chen, Jiajia Wan, Zhuoyu Gu, Xiaomeng Liu, Ming Wang, Linyu Zhu, Yongjuan Li and Yu Zhang. Their work appears in journals such as International Journal of Biological Sciences, Journal of Controlled Release, iScience, Oncogenesis and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.